Joanne Davies

ORCID: 0000-0003-0318-1380
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Lipoproteins and Cardiovascular Health
  • Cardiac tumors and thrombi
  • Pediatric Hepatobiliary Diseases and Treatments
  • Birth, Development, and Health
  • Coronary Interventions and Diagnostics
  • Gallbladder and Bile Duct Disorders
  • Neuroendocrine Tumor Research Advances
  • Pancreatic and Hepatic Oncology Research
  • Respiratory and Cough-Related Research
  • Folate and B Vitamins Research
  • Growth Hormone and Insulin-like Growth Factors
  • Pancreatitis Pathology and Treatment
  • Pediatric health and respiratory diseases

University of Oxford
2017-2023

Bristol Robotics Laboratory
2016-2017

Southmead Hospital
2015

University of Bristol
2015

Systemic glucocorticoids are recommended for use in chronic obstructive pulmonary disease (COPD) exacerbations; however, there is increased harm associated with their use. We hypothesised that the of eosinophil biomarker-directed oral prednisolone therapy at time an exacerbation COPD was effective reducing without affecting adverse outcomes.

10.1016/s2213-2600(23)00298-9 article EN cc-by The Lancet Respiratory Medicine 2023-11-02

Near-patient testing (NPT) allows clinical decisions to be made in a rapid and convenient manner is often cost effective. In COPD the peripheral blood eosinophil count has been demonstrated have utility providing prognostic information predicting response treatment during an acute exacerbation. For this potential achieved having reliable NPT of would extremely useful. Therefore, we investigated use HemoCue® WBC Diff System evaluated its sensitivity specificity healthy, asthmatic subjects....

10.2147/copd.s147216 article EN cc-by-nc International Journal of COPD 2017-09-01

"The use of magnetic resonance cholangiopancreatography in the management biliary tract disease pregnancy." Journal Obstetrics and Gynaecology, 19(6), pp. 656–657

10.1080/01443619963996 article EN Journal of Obstetrics and Gynaecology 1999-01-01

<b>Introduction:</b> The majority of COPD patients are seen in primary care, where approximately 1.4 million acute exacerbations treated, but little is known about the inflammatory phenotype or response to treatment at time an exacerbation. peripheral blood eosinophil (PBE) count can be measured from a single drop &amp; inform clinicians phenotype. We conducted prospective observational study with Thames Valley region understand characteristics (Stratified TreAtment Reduce Risk COPD: STARR...

10.1183/1393003.congress-2017.pa1095 article EN 05.02 - Monitoring airway disease 2017-09-01

<b>Introduction:</b> The COPD STARR study (Stratified TreAtment to Reduce Risk in COPD) is an observational performed GP practices the Thames Valley region understand inflammatory characteristics COPD. To maximise recruitment, a new peripatetic research model was performed, with two dedicated nurses aligned 8 over large geographical area. <b>Methods:</b> Subjects COPD, defined according clinical history &amp; spirometry, were entered into study. Data sampling at entry included baseline...

10.1183/1393003.congress-2017.pa943 article EN 2017-09-01
Coming Soon ...